Ferring Pharmaceuticals has purchased a 25-acre site in Parsippany, NJ that will house an expanded U.S. Operations Center. The facility will serve as an integrated pharmaceutical center and will house management, administration and support, commercial operations, manufacturing and product development, including a manufacturing suite, product development labs, an education and training conference center, and administrative offices.

“As a private company, Ferring has a long term orientation, as well as a commitment to follow the science to benefit patients. This new facility underscores our long-term commitment to the U.S. market, as well as the State of New Jersey,” said Aaron Graff, president and chief operating officer of Ferring Pharmaceuticals, Inc. “Together with our Global Research Center in San Diego, this symbolizes our focus on accelerating Ferring growth in the U.S.  The local community has continuously expressed support for our endeavors, and we are so pleased to expand our operations in an area with such a large base of talented, highly trained pharmaceutical professionals.”